Evidence map›Paper›PMID 39551922›Full record

ArticleHealthcare informatics research2024

Mapping Drug Terms via Integration of a Retrieval-Augmented Generation Algorithm with a Large Language Model.

Eizen Kimura, Yukinobu Kawakami, Shingo Inoue, Ai Okajima

Abstract read
In one paragraph

Article in Healthcare informatics research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eizen KimuraDepartment of Medical Informatics, Medical School of Ehime University, Toon, Ehime, Japan.
Yukinobu KawakamiDepartment of Medical Informatics, Medical School of Ehime University, Toon, Ehime, Japan.
Shingo InoueYuimedi Inc., Tokyo, Japan.
Ai OkajimaYuimedi Inc., Tokyo, Japan.

Funding

Ministry of Education, Culture, Sports, Science, and Technology
6 · The paper itself

Abstract

objectivesThis study evaluated the efficacy of integrating a retrieval-augmented generation (RAG) model and a large language model (LLM) to improve the accuracy of drug name mapping across international vocabularies.

methodsDrug ingredient names were translated into English using the Japanese Accepted Names for Pharmaceuticals. Drug concepts were extracted from the standard vocabulary of OHDSI, and the accuracy of mappings between translated terms and RxNorm was assessed by vector similarity, using the BioBERT-generated embedded vectors as the baseline. Subsequently, we developed LLMs with RAG that distinguished the final candidates from the baseline. We assessed the efficacy of the LLM with RAG in candidate selection by comparing it with conventional methods based on vector similarity.

resultsThe evaluation metrics demonstrated the superior performance of the combined LLM + RAG over traditional vector similarity methods. Notably, the hit rates of the Mixtral 8x7b and GPT-3.5 models exceeded 90%, significantly outperforming the baseline rate of 64% across stratified groups of PO drugs, injections, and all interventions. Furthermore, the r-precision metric, which measures the alignment between model judgment and human evaluation, revealed a notable improvement in LLM performance, ranging from 41% to 50% compared to the baseline of 23%.

conclusionsIntegrating an RAG and an LLM outperformed conventional string comparison and embedding vector similarity techniques, offering a more refined approach to global drug information mapping.

Indexed as

Computer Neural NetworkControlled VocabularyMachine LearningRxNormTerminology

Identifiers

PMID39551922
PMCPMC11570653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.